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The formula proposed by Rich in 1951 explained the formation in a tuberculous lesion in
a  period that was unknown cellular functions, cytokines and other immunological aspects
involved  in granuloma formation by tuberculosis; its components are assembled concep-
tually  to explain the pathogenic mechanisms involved in the granulomatous lesion in
tuberculosis.  In this manuscript, we report an update of Rich’s formula based on the new
and  old concepts about pathogenic mechanisms involved in the granulomatous lesion inImmunopathogenesis
Granuloma
Hypersensitivity
tuberculosis.  Current knowledge allows us to conclude that the balance between the charac-
teristics of the bacillus and host protective response is necessary to indicate the outcome of
pathogenesis, infection or active disease and the necrosis degree of the tuberculosis lesion.
© 2013 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-NDIntroduction
Tuberculosis (TB) is the most frequent cause of granulo-
mas  and is the most prevalent infectious disease in Brazil,
remaining one the most important problems of public health
in  the world. In 2010, 71,000 cases were reported, with a mor-
tality  of 4800/year.1 Brazil is the 19th in rank among countries
with  the majority of TB cases in the world. Bahia, the north-
east  State of Brazil, is ranked 3rd in number of cases, after São
Paulo  and Rio de Janeiro. TB incidence in Bahia is 39.5/100,000
habitants.1–3
TB is a granulomatous disease characterized by a
cell-mediated hypersensitivity reaction in response to com-
ponents  of the wall structure of Mycobacterium tuberculosis
especially cord factor and lipoarabinomannan.4 Granuloma
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Este é um artigo Open Access sob a licençawas  ﬁrst described in 1679 by Sylvius, and etymologically
comes from the original word tubercle.5 Nowadays, granulo-
mas  are much  better understood based on the knowledge of
cellular  immunology (cell mediated hypersensitivity reaction)
and  its interaction with cytokines and chemokines.
In 1951, Rich proposed that the pathogenesis of tuberculous
lesion was  directly dependent of inoculum, bacillus number
(N),  bacilli virulence (V) and host hypersensitivity (H), by coun-
terbalancing  and decreasing the lesion size, the natural and
acquired  resistance of the host (Rn + a). This formula can be
represented by6:
N + V + Heira, João Carlos Coelho Filho, Fundac¸ão  José Silveira, Ladeira do
L =
R(n+a)
Rich’s formula shows components that are assembled con-
ceptually  to explain the pathogenic mechanisms involved in
 de CC BY-NC-ND
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he granulomatous lesion in TB. Considering the TB patho-
enesis  in two different clinical forms, infection and disease,
here  in infection, the balance depends on the host natural
esistance. In contrast, in disease, the balance depends on the
acilli  properties such as virulence and hypersensitivity phe-
omenon.  In both clinical forms, either infection or disease,
ranulomas are detected in the tissue.7–9 Both stages are tak-
ng  place inside of the granuloma, where the components of
ich’s  formula occur. The ancient concept was  that a granu-
oma  was  a cellular agglomerate walling of the bacilli; thus in
ich’s  formula this should be considered in the denominator.
his  can be observed in some host, in which the granuloma
ormation is impaired and therefore the bacillus growth is
aster.  In fact, in these almost 60 years since the proposi-
ion  of Rich’s formula, the science has advanced signiﬁcantly
n  the knowledge of the properties of M. tuberculosis, as well
s  in understanding of host defense mechanisms. These new
oncepts  have been incorporated into the above formula.
nitiation  of  infection  and  granuloma  formation
fter mycobacterial arrival in the tissues of the respiratory
ract, an unspeciﬁed reaction occurs in which neutrophils
ry  to phagocytize the bacillus. This initial phase is not well
tudied  in humans.10 Three weeks later, there is a develop-
ent within these tissues of a more  speciﬁc reaction, when
ononuclear cells reach the focus of the infectious lesion,
odulating the granuloma formation.9,11,12 Mononuclear cells
ncluding  monocytes/macrophages and lymphocytes, cells
ith  their predeﬁned morphologies and functions, partici-
ate  in the recognition and presentation of components of
.  tuberculosis to the immune system.11–13 During and after
ononuclear cells naïve starts cells differentiation into spe-
iﬁc  cell types such as macrophages, dendritic cells, CD4 and
D8  T helper.14
In the process of granuloma formation, many  macrophages
ith large cytoplasm and organelles with high phagocytic
nd  microbicidal functions were observed.15–17 These cells can
use  into multinucleated giant cells; however, these changes
re  not completely understood.12,17 Mature macrophages can
ndergo  a transformation into epithelioid cells (epithelioid
istiocytes), which interdigitated their membranes aggregat-
ng  into other cells as the epithelial barrier.16 CD4 and CD8
 helper (Th) lymphocytes as well as epithelioid monocytes
nd  giant multinucleated cells participate in this granuloma
ormation that is orchestrated by INF- produced by CD4 and
NF-  secreted by macrophages.8,11,12,15,18 Other cells, such
s neutrophils, join this granuloma via a dynamic process.9,19
ll these facts have dynamic morphology that is inﬂuenced
y  the balance between host resistance and the M.  tuberculosis
irulence gene expression.9,11
Cellular apoptosis of caseous necrosis can also be detected
ithin  the centers of granulomas. Progress has been made
n  determining these mechanisms; however, much  remains
ot  completely understood.9 One interesting point that has
een  found regards the function of the granuloma. Although
he  main consensus is that the granuloma that surrounds the
.  tuberculosis is doing so in an attempt to restrict it from
preading.20 Other experiments in the zebraﬁsh have shown3;1  7(2):234–238  235
that  granuloma also contribute to bacilli spreading. During the
granuloma’s  formation the tissues are injured and necrosis
develops. This mechanism of lesion development depends on
the acquired resistance versus the hypersensitivity developed
by  the patient to the bacillus during the infection.9
Granulomas seen in tuberculous pleurisy allow to distin-
guish  the cellular components comparing the cells present
in  pleura ﬂuid.21 Fayyazi et al. showed a possible apoptosis
of  epithelioid cells and the presence of CD4 T lymphocytes
in the proximity of the focus of the necrosis. Such ﬁndings
could  suggest a direct relation between the cells, their sec-
retions  and the central necrosis of granulomas, in addition to
the epithelioid cell’s apoptosis.22 The interaction of all these
aspects  and also the elements of the extracellular matrix9 are
part  of the ﬁnal product, the granuloma with central caseous
necrosis.23,24
Bacilli  virulence
The genome sequence of M.  tuberculosis allowed to conduct
studies  about the role of unknown genes through functional
genomics. The identiﬁcation of genes present in hypervirulent
strains of M.  tuberculosis,25 but absent in pathogenic strains
such  as Mycobacterium bovis BCG, allowed a better understand-
ing  of the pathogenesis of TB.
Currently, the virulence of M.  tuberculosis is deﬁned by
region  of difference (RD1) genes, which are absent in BCG
strains  and are present in all M. tuberculosis virulent strains.
Several  studies have demonstrated that deletion of RD1 from
M.  tuberculosis results in attenuation of virulence, suggest-
ing  a dominant role in immune responses.26,27 Thus, deletion
mutants of virulent M. tuberculosis strains for RD1  resemble
BCG  in their infectivity and attenuation.27
Furthermore, another group of genes have been associ-
ated  with virulence of M.  tuberculosis in animal model. It
is  suggested that the mammalian cell entry genes (mce),
which  encodes Mce protein, were originally identiﬁed in M.
tuberculosis28 and have been associated with survival within
macrophages and an increase in virulence.29,30 Disruption of
the  mce  gene of BCG results in a mutant that exhibits reduced
invasiveness epithelial cells, impairing their ability to survive
and  multiply inside phagocytic cells.31
Inhibition of macrophage apoptosis by M. tuberculosis strain
H37Rv  has been proposed as another virulence mechanism.32
This hypothesis is supported by studies that show that
bacilli  can cause necrosis instead of apoptosis in infected
macrophages to avoid innate host defense. The macrophage
cell  death pathway by necrosis could be an exit mechanism
for  M.  tuberculosis to facilitate the spread of infection and con-
tribute  to the formation of necrotic lesions in TB.33,34 Indeed,
infection of macrophages with the attenuated M.  tuberculo-
sis  causes apoptosis, which limits bacterial replications and
promotes  T-cell cross priming by antigen-presenting cells.35
Host  hypersensitivityThere is a strong relationship among immunity and hyper-
sensitivity in TB. T lymphocytes can produce distinct types of
i s . 2 0
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immune responses associated with different cytokine proﬁles
and  have opposing effects on resistance and susceptibility.14
The result of this balance will determine the degree of
lesion  in infected individuals and TB disease. Latent infec-
tion  is associated with protective cellular immune responses
whereas  advanced disease is associated with immune sup-
pression  and exacerbated hypersensitivity reaction, causing
tissue  damage. Thus, T lymphocytes may  also mediate harm-
ful  tissue-destroying hypersensitivity reactions that cause
progression of disease.36
Natural  and  acquired  resistance
Macrophages, dendritic cells and neutrophils principally
mediate the natural host resistance to M. tuberculosis. The
available  data on the role of neutrophils are controversial.
Neutrophils are the ﬁrst cells to be mobilized and arrive within
hours  at the site of infection. They are not professional phago-
cytes  such as macrophages, but contribute substantially to
innate  resistance to infection. Neutrophils can also form an
extracellular  ﬁbril matrix known as NETs (neutrophil extracel-
lular  traps). These NETs were described recently.37 They are
formed  by activated neutrophils and consist of a DNA back-
bone  with embedded antimicrobial peptides and enzymes.
Thus,  NETs represent a distinct innate defense mechanism
to  control and eliminate microbial infections.38 On the other
hand,  the poor ability of neutrophils to restrict mycobacte-
rial  growth compared to alveolar macrophages indicates that
the  prevalence of neutrophils in TB inﬂammation contributes
to  the development of a nonspeciﬁc cellular reaction, rather
than  protection of the host, and that neutrophils may  play
the  role of a “Trojan horse” for M. tuberculosis.10,39 Indeed,
interferon-inducible neutrophil-driven blood transcriptional
signature has been described in patients with active TB, which
correlates  with lung radiographic disease severity and impli-
cates  neutrophils directly in the pathogenesis of active TB.40
Molecular studies show that the human genetic are
responsible for natural resistance to M. tuberculosis. There is
consensus in the literature that humans exposed to Mycobac-
terium  millennially were evolutionarily selected, providing
relatively more  resistant cohorts. One example of this is the
infection  of Native Americans when Europeans ﬁrst came to
North America where the Apaches tribe was  rapidly infected
by  acute and deadly TB.41 Also, indigenous Brazilians show a
high  TB rate, which can be attributable to an intrinsic suscep-
tibility  of these individuals.42
The resistance mechanism in TB involves a great number
of  cellular interactions (macrophage, T cell). Several different
T-cell  populations are required for the successful control of
the  pathogen. This dynamic interplay underlying protection
is  the reason for the long-term persistence of M. tuberculo-
sis.  From the cellular point of view the T lymphocytes are
differentiated in the thymus. CD4 and CD8 T-cells activate
macrophages against M. tuberculosis. These cells recognize
speciﬁc parts of the bacillus and secrete cytokines, which
9,11–15,18activate  macrophages. T cells also act, induced by
components of the bacillus, producing defense mechanisms.
By  reacting with proteins, a state of hypersensitivity is cre-
ated  that can be measured by the tuberculin test. In this 1 3;1 7(2):234–238
context,  cytokines play an important role in the pathogenesis
of  TB. The cytokines are weighted molecules of about 8–14 kDa
whose  production is a function of the components of M. tuber-
culosis.  These cytokines attract macrophages that transform
into  epithelioid cells.8,9,14 IFN-, TNF- and interleukin-(IL)-12
are the most fundamental cytokines, but there are currently
about  40 classiﬁed cytokines and other chemokines that act as
receptors involved in the cellular dynamic of granulomas.43
The events underlying the structural reorganization of
immune  cells to form a stable granuloma or progress to a
pathologic  lesion are dependent on other components. It is
related  with some components of the structure of M.  tuber-
culosis,  including some parts of its genetic material. These
elements can mobilize, recruit, and amplify T cells reaction
through the inﬂuence of cytokines.44 Glycolipids, components
of  the M. tuberculosis wall (sero-lipidic membrane), also involve
the  bacillus and DNA. They contain a 6 kDa protein, designed
as  an ESAT-6, that mobilizes the T cell and activates the pro-
duction  of TNF- and IFN-. Both of these activations lead the
macrophages to destroy the Mycobacterium.19,45 Following the
above  events, as well as the arrival of bacilli in the tissues (for
example,  pulmonary alveoli), the formation of a granuloma
with  central caseous necrosis is completed.
Directed by T lymphocytes, modiﬁed monocytes aggre-
gate  and transform into epithelioid cells. With this fusion,
giant  multinucleated cells (Langerhans cells) are created. The
dynamic  previously described is also inﬂuenced by TNF-.44
In addition to Langerhans cells, TNF- also plays a role in
the  formation of caseous necrosis within the center of the
granuloma.9,44 The anaerobic environment and the action of
phagolysosomes within the granulomas inhibit the spread
of  bacilli. The hypersensitivity promotes the progression to
necrosis,  making the cells more  sensitive to the components of
the  bacillus (for example, tuberculostearic acid). The ﬁnal dif-
ferentiation  of the granuloma will depend on the interplay of
all  the factors cited in this paper. When there is high immunity
and  low hypersensitivity there will be a low level of necrosis
and  the granuloma will most likely scar under the action of
mioﬁbroblasts. If the hypersensitivity is dominant, the necro-
sis  will spread and the lesion will grow with an increase in the
proliferation  of bacilli.46
In conclusion, although Rich’s formula was proposed in the
1950s,  it still holds some relevance to the distinct components
within the granulomatous lesions. Even after incorporation of
current  knowledge about pathogenesis of M. tuberculosis, the
balance  between the characteristics of the bacillus and the
host  protective response is necessary to indicate the outcome
of  infection.
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